Steris Healthcare Announces INR 50 Cr Expansion & IPO Plans

The company stated that this move is intended to streamline supply chains and enhance its reach in key regions.

Steris Healthcare, a pharmaceutical startup with operations in Navi Mumbai, has announced an INR 50 crore expansion strategy and plans to launch its Initial Public Offering (IPO) in the financial year 2026–27.

As part of this development, the company will set up a new manufacturing facility in South India.

The proposed plant will serve the markets of Kerala, Tamil Nadu, Hyderabad (Telangana), and Bengaluru (Karnataka). The company stated that this move is intended to streamline supply chains and enhance its reach in key regions.

New Plant to Support Southern Markets and Double Output

The upcoming facility will double Steris Healthcare’s production capacity. While the number of added units has not been disclosed, the expansion will increase the company’s ability to meet rising domestic and international demand.

Steris Healthcare also plans to launch new medications and healthcare products under this expansion. According to the company, these products aim to address critical therapeutic needs. Specific therapeutic categories or products have not been named in the announcement.

Expansion to Generate 800 Jobs; IPO Set for FY 2026-27

The expansion is expected to generate 800 new jobs across functions such as manufacturing, research and development, sales, and logistics. These roles will be based in South India, aligning with the new facility's location.

In addition to infrastructure expansion, Steris Healthcare has confirmed its intent to go public. The IPO is planned for FY 2026–27 and will support various growth objectives. These include scaling infrastructure, advancing R&D efforts, and expanding market reach. The company is working with financial advisors to align with regulatory requirements and prepare for the offering.

Steris Healthcare recently crossed INR 100 crore in annual sales. No further details have been shared regarding the project timelines or IPO size.